Figure 1 Proportion Of Patients Achieving Differing Levels (Zonisamide Fig1)
Zonisamide Capsule
Product Images NDC 59651-378
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Zonisamide (NDC 59651-378). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Package Label Principal Display Panel (25 mg (30 Tablet Bottle))
Package Label Principal Display Panel (50 mg (30 Tablet Bottle))
This is a description of Zonisamide Capsules containing 50 mg of the active ingredient, sold by Aurobindo Pharma USA, Inc. The drug is only available by prescription and the full prescribing information is included in the package insert. The medication guide is provided separately to each patient. The capsules should be stored at room temperature in a dry place and protected from light. The dotted lines indicate an over printing zone coding area.*
Package Label Principal Display Panel (100 mg (30 Tablet Bottle))
Zonisamide Capsules, USP is a medication distributed by Aurobindo Pharma USA, Inc. The usual dosage is to be referred to the package insert for complete prescribing information. The capsules contain 100 mg of the active ingredient Zonisamide USP. The medication guide should be dispensed separately to each patient. The capsules should be stored in a dry place and protected from light at 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F).*
Chemical Structure (Zonisamide Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
